Investigating factors affecting glioblastoma outcomes
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
This study is looking to see how different health and lifestyle factors affect the survival and quality of life for adults with glioblastoma, a tough type of brain cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT06625684 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify the various factors that influence health outcomes and risks in adults diagnosed with glioblastoma, a highly aggressive brain cancer. Participants will complete an online survey regarding their medical history and lifestyle, and may provide a blood sample for genetic and immune system testing. The study will follow participants over time to observe how these factors impact survival and quality of life. Insights gained may lead to personalized treatment strategies and improved risk assessment tools for glioblastoma management.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a pathologically-confirmed diagnosis of glioblastoma multiforme.
Not a fit: Patients who cannot read English or Spanish or those unable to complete an online survey may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of glioblastoma and lead to improved management strategies for patients.
How similar studies have performed: Other studies have explored factors affecting glioblastoma outcomes, but this specific approach focusing on genetic and immune factors is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years old * Pathologically-confirmed diagnosis of glioblastoma multiforme (GBM) or grade 4 brain tumor * Participant is accessible for follow-up (has a working email address) * Participant is willing and able to comply with the study requirements Exclusion Criteria: * Those who cannot read either English or Spanish * Those who cannot view an online survey
Where this trial is running
Durham, North Carolina
- Duke University — Durham, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Quinn Ostrom, PhD — Duke University
- Study coordinator: Quinn Ostrom, PhD
- Email: GBMsurvey@duke.edu
- Phone: 919 -684-5301
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.